Orphazyme Company

Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.

Investors

Industry: Loss of Proteostasis
Headquarters: Denmark
Visit Website
contact@orphazyme.com
Register and Claim Ownership